Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
COVID-19
Glycemic control-lockdown
Type 2 diabetes mellitus
Weight change
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
17
12
2020
accepted:
21
04
2021
pubmed:
6
5
2021
medline:
22
6
2021
entrez:
5
5
2021
Statut:
ppublish
Résumé
The aim of this study was to evaluate the impact of the COVID-19 lockdown occurred in Italy from March 9th to May 18th, 2020 on anthropometric parameters and glycemic control in patients with type 2 diabetes mellitus (T2DM). One hundred twenty-eight consecutive patients with T2DM (median age 70 years, 74 males) were retrospectively evaluated at the end of the lockdown period. Data on metabolic control were collected at different time: within three months before the lockdown (visit 0) and within the first six weeks after it (visit 1). During the lockdown, a significant increase in body weight (from 79.7 ± 18.7 kg to 81.4 ± 19.4 kg, p < 0.001), body mass index (BMI, from 29.5 ± 6 kg/m The lockdown due to COVID-19 pandemic had a negative impact on body weight and glucose control in T2DM patients, in particular in those on insulin treatment. This finding provides a further rationale to optimize the diabetes management during eventually new period of home confinement.
Identifiants
pubmed: 33950348
doi: 10.1007/s12020-021-02739-5
pii: 10.1007/s12020-021-02739-5
pmc: PMC8098639
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
604-610Références
L. Rosenbaum, The untold toll — the pandemic’s effects on patients without Covid-19. N. Engl. J. Med. 382, 2368–2371 (2020). https://doi.org/10.1056/NEJMms2009984
doi: 10.1056/NEJMms2009984
pubmed: 32302076
S.R. Bornstein, F. Rubino, K. Khunti, G. Mingrone, D. Hopkins, A.L. Birkenfeld et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 8, 546–550 (2020). https://doi.org/10.1016/S2213-8587(20)30152-2
doi: 10.1016/S2213-8587(20)30152-2
pubmed: 32334646
pmcid: 7180013
C. Koliaki, A. Tentolouris, I. Eleftheriadou, A. Melidonis, G. Dimitriadis, N. Tentolouris, Clinical management of diabetes mellitus in the era of COVID-19: practical issues, peculiarities and concerns. J. Clin. Med. 9, 2288 (2020). https://doi.org/10.3390/jcm9072288
doi: 10.3390/jcm9072288
pmcid: 7408673
L. Di Renzo, P. Gualtieri, F. Pivari, L. Soldati, A. Attinà, G. Cinelli et al. Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J. Transl. Med. 18, 229 (2020). https://doi.org/10.1186/s12967-020-02399-5
doi: 10.1186/s12967-020-02399-5
pubmed: 32513197
pmcid: 7278251
A. Pietrobelli, L. Pecoraro, A. Ferruzzi, M. Heo, M. Faith, T. Zoller et al. Effects of COVID‐19 lockdown on lifestyle behaviors in children with obesity living in Verona, Italy: a longitudinal study. Obesity 28, 1382–1385 (2020). https://doi.org/10.1002/oby.22861
doi: 10.1002/oby.22861
pubmed: 32352652
pmcid: 32352652
M. Pellegrini, V. Ponzo, R. Rosato, E. Scumaci, I. Goitre, A. Benso et al. Changes in weight and nutritional habits in adults with obesity during the “lockdown” period caused by the COVID-19 virus emergency. Nutrients 12, 2016 (2020). https://doi.org/10.3390/nu12072016
doi: 10.3390/nu12072016
M.J. Davies, D.A. D’Alessio, J. Fradkin, W.N. Kernan, C. Mathieu, G. Mingrone et al. Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 41, 2669–2701 (2018). https://doi.org/10.2337/dci18-0033
doi: 10.2337/dci18-0033
pubmed: 30291106
pmcid: 30291106
American Diabetes Association, 5. Lifestyle management: standards of medical care in diabetes-2019. Diabetes Care 42, S46–S60 (2019). https://doi.org/10.2337/dc19-S005
doi: 10.2337/dc19-S005
A.D. Association, 1. Improving care and promoting health in populations: standards of medical care in diabetes — 2020. Diabetes Care 43, S7–S13 (2020). https://doi.org/10.2337/dc20-S001
doi: 10.2337/dc20-S001
E. Fernández, A. Cortazar, V. Bellido, Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res. Clin. Pr. 166, 108348 (2020). https://doi.org/10.1016/j.diabres.2020.108348
doi: 10.1016/j.diabres.2020.108348
P. Sankar, W.N. Ahmed, V. Mariam Koshy, R. Jacob, S. Sasidharan, Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: a hospital-based cross-sectional survey from South India. Diabetes Metab. Syndr. Clin. Res. Rev. 14, 1815–1819 (2020). https://doi.org/10.1016/j.dsx.2020.09.005
doi: 10.1016/j.dsx.2020.09.005
B. Capaldo, G. Annuzzi, A. Creanza, C. Giglio, R. De Angelis, R. Lupoli et al. Blood glucose control during lockdown for COVID-19: CGM metrics in Italian adults with type 1 diabetes. Diabetes Care 43, e88–e89 (2020). https://doi.org/10.2337/dc20-1127
doi: 10.2337/dc20-1127
pubmed: 32540921
pmcid: 7372051
R.M. Anjana, R. Pradeepa, M. Deepa, S. Jebarani, U. Venkatesan, S.J. Parvathi et al. Acceptability and utilization of newer technologies and effects on glycemic control in type 2 diabetes: lessons learned from lockdown. Diabetes Technol. Ther. 22, 527–534 (2020). https://doi.org/10.1089/dia.2020.0240
doi: 10.1089/dia.2020.0240
pubmed: 32522031
A. Verma, R. Rajput, S. Verma, V.K.B. Balania, B. Jangra, Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus. Diabetes Metab. Syndr. Clin. Res. Rev. 14, 1213–1216 (2020). https://doi.org/10.1016/j.dsx.2020.07.016
doi: 10.1016/j.dsx.2020.07.016
M. Longo, P. Caruso, M. Petrizzo, F. Castaldo, A. Sarnataro, M. Gicchino et al. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy. Diabetes Res. Clin. Pr. 169, 108440 (2020). https://doi.org/10.1016/j.diabres.2020.108440
doi: 10.1016/j.diabres.2020.108440
Bonora B.M., Boscari F., Avogaro A., Bruttomesso D., Fadini G.P. Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy. 2020; 76949 Bytes. https://doi.org/10.6084/M9.FIGSHARE.12162024.V1
Mirani M., Favacchio G., Carrone F., Betella N., Biamonte E., Morenghi E., et al. Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: a case series from an academic hospital in Lombardy, Italy. Diabetes Care. 2020. https://doi.org/10.2337/dc20-1340
A. Ceriello, E. Standl, D. Catrinoiu, B. Itzhak, N.M. Lalic, D. Rahelic et al. Issues of cardiovascular risk management in people with diabetes in the COVID-19 era. Diabetes Care 43, 1427–1432 (2020). https://doi.org/10.2337/dc20-0941
doi: 10.2337/dc20-0941
pubmed: 32409501
A. Kumar, A. Arora, P. Sharma, S.A. Anikhindi, N. Bansal, V. Singla et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab. Syndr. Clin. Res. Rev. 14, 535–545 (2020). https://doi.org/10.1016/j.dsx.2020.04.044
doi: 10.1016/j.dsx.2020.04.044
I. Huang, M.A. Lim, R. Pranata, Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression. Diabetes Metab. Syndr. Clin. Res. Rev. 14, 395–403 (2020). https://doi.org/10.1016/j.dsx.2020.04.018
doi: 10.1016/j.dsx.2020.04.018
M.B. Ruiz-Roso, C. Knott-Torcal, D.C. Matilla-Escalante, A. Garcimartín, M.A. Sampedro-Nuñez, A. Dávalos et al. COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients 12, 2327 (2020). https://doi.org/10.3390/nu12082327
doi: 10.3390/nu12082327
pmcid: 7468739
A.J. Ahola, S. Mutter, C. Forsblom, V. Harjutsalo, P.-H. Groop, Meal timing, meal frequency, and breakfast skipping in adult individuals with type 1 diabetes – associations with glycaemic control. Sci. Rep. 9, 20063 (2019). https://doi.org/10.1038/s41598-019-56541-5
doi: 10.1038/s41598-019-56541-5
pubmed: 31882789
pmcid: 6934661
K. Rechenberg, R. Whittemore, M. Holland, M. Grey, General and diabetes-specific stress in adolescents with type 1 diabetes. Diabetes Res. Clin. Pr. 130, 1–8 (2017). https://doi.org/10.1016/j.diabres.2017.05.003
doi: 10.1016/j.diabres.2017.05.003
N. Shah, M. Karguppikar, S. Bhor, D. Ladkat, V. Khadilkar, A. Khadilkar, Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes. J. Pediatr. Endocrinol. Metab. 34, 217–223 (2021). https://doi.org/10.1515/jpem-2020-0460
doi: 10.1515/jpem-2020-0460
pubmed: 33185578
S.-Y. Chen, H.-C. Hsu, R.-H. Wang, Y.-J. Lee, C.-H. Hsieh, Glycemic control in insulin-treated patients with type 2 diabetes: empowerment perceptions and diabetes distress as important determinants. Biol. Res Nurs. 21, 182–189 (2019). https://doi.org/10.1177/1099800418820170
doi: 10.1177/1099800418820170
pubmed: 30585081
Zuo P., Shi J., Yan J., Yang L., Liu C., Yuan L., et al. Effects of insulin therapy and oral hypoglycemic agents on glycemic control for type 2 diabetes mellitus patients in china–a case control study. Exp Clin Endocrinol Diabetes. 2019; a-0881-9611. https://doi.org/10.1055/a-0881-9611